## Abstract With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant characteristics, __e.g__., fertility rate, ageβofβmother at first birth and a national screening programme for several years. The aim of this study is to compare trends in incidence of and
Trends in cervical cancer in the Netherlands until 2007: Has the bottom been reached?
β Scribed by Inge M.C.M. de Kok; Maaike A. van der Aa; Marjolein van Ballegooijen; Sabine Siesling; Henrike E. Karim-Kos; Folkert J. van Kemenade; Jan Willem W. Coebergh; on behalf of the Working Group Output of the Netherlands Cancer Registry
- Book ID
- 102865247
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 531 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We explored trends in incidence and mortality of cervical cancer by age, stage and morphology, and linked the observed trends to screening activities. Data was retrieved from the Netherlands Cancer Registry during 1989β2007 (incidence) and Statistics Netherlands during 1970β2007 (mortality). Trends were evaluated by calculating the estimated annual percentage change (EAPC). Joinpoint regression analysis was used to detect changes in trends. Cervical intraepithelial neoplasia (CIN) detection rates were calculated by data from βthe nationwide network and registry of histoβ and cytopathologyβ during 1990β2006. Total ageβadjusted incidence rate (European standardized rate (ESR)) was 7.9 per 100,000 woman years in 2007. During 1989β1998, incidence rates decreased with an EAPC of β1.3% (95% confidence interval (CI) β2.2 to β0.3), during 1998β2001 with β6.7% (95% CI: β16.4 to 4.1), and increased during 2001β2007 with 2.3% (95% CI: 0.4 to 4.2). Total mortality ESR was 1.9 per 100,000 woman years in 2007. Mortality rates decreased during 1970β1994 annually with β4.1% (95% CI: β4.6% to β3.7%), and with β2.6% (95% CI: β3.8% to β1.5%) during 1994β2007. The observed trend in total incidence is similar to the trend in squamous cell carcinomas in age group 35β54 years, suggesting that the observed trends are likely to be associated to changes in the screening program. This is supported by the trend in CINIII detection rates. In conclusion, incidence and mortality overall decreased and leveled off. On top of that there was an extra decrease that was compensated by a following recent increase in incidence, probably resulting from reorganization of the Dutch screening program.
π SIMILAR VOLUMES